Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

249: Have the new diagnostic criteria for gestational diabetes mellitus (GDM) impacted on perinatal maternal and fetal outcomes?

249: Have the new diagnostic criteria for gestational diabetes mellitus (GDM) impacted on... <h5>Objective</h5> The International Association of Diabetes and Pregnancy Study Group (IADPSG) recently adopted new criteria for the diagnosis of GDM based on the results of the Hyperglycaemia and Adverse Pregnancy Outcomes (HAPO) trial. These criteria for diagnosis were adopted by our unit in 2011.</P>The aim of our study was to determine the difference in perinatal outcomes in 3 separate groups and to provide information on these women who are now deemed to have gestational diabetes.</P>The patients in Group 2 and 3 received treatment in a tertiary referral unit for the management of GDM.</P><h5>Study Design</h5> A prospective study of oral glucose tolerance tests (OGTTs) performed in a large tertiary referral hospital with a delivery rate of greater than 8,500 births per year. The presence of GDM and perinatal outcomes were compared in three groups. Group 1=Not GDM. Group 2 =GDM. Group 3= Additional women diagnosed GDM based on new criteria.</P><h5>Results</h5> 1590 patients had OGTT results and complete data recorded in 2011.The number of women with GDM using the new criteria was increased by 26.4%. The extra women had an increased BMI at booking (p=0.001) but there was no increase in shoulder dystocia or pre-eclampsia. There was no difference in caesarean section rates ( Table ). </P><h5>Conclusion</h5> The new diagnostic criteria for GDM will result in an increased rate of diagnosis of GDM and therefore increased surveillance of these patients. However this treatment will not improve perinatal outcome, we may now be diagnosing and treating a group of women without sufficient evidence of clinical benefit.</P> http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Obstetrics and Gynecology Wolters Kluwer Health

249: Have the new diagnostic criteria for gestational diabetes mellitus (GDM) impacted on perinatal maternal and fetal outcomes?

Loading next page...
 
/lp/elsevier/249-have-the-new-diagnostic-criteria-for-gestational-diabetes-mellitus-xMz4Ffupj4
Publisher
Wolters Kluwer Health
Copyright
Copyright © 2013 Mosby, Inc.
ISSN
0002-9378
DOI
10.1016/j.ajog.2012.10.414
Publisher site
See Article on Publisher Site

Abstract

<h5>Objective</h5> The International Association of Diabetes and Pregnancy Study Group (IADPSG) recently adopted new criteria for the diagnosis of GDM based on the results of the Hyperglycaemia and Adverse Pregnancy Outcomes (HAPO) trial. These criteria for diagnosis were adopted by our unit in 2011.</P>The aim of our study was to determine the difference in perinatal outcomes in 3 separate groups and to provide information on these women who are now deemed to have gestational diabetes.</P>The patients in Group 2 and 3 received treatment in a tertiary referral unit for the management of GDM.</P><h5>Study Design</h5> A prospective study of oral glucose tolerance tests (OGTTs) performed in a large tertiary referral hospital with a delivery rate of greater than 8,500 births per year. The presence of GDM and perinatal outcomes were compared in three groups. Group 1=Not GDM. Group 2 =GDM. Group 3= Additional women diagnosed GDM based on new criteria.</P><h5>Results</h5> 1590 patients had OGTT results and complete data recorded in 2011.The number of women with GDM using the new criteria was increased by 26.4%. The extra women had an increased BMI at booking (p=0.001) but there was no increase in shoulder dystocia or pre-eclampsia. There was no difference in caesarean section rates ( Table ). </P><h5>Conclusion</h5> The new diagnostic criteria for GDM will result in an increased rate of diagnosis of GDM and therefore increased surveillance of these patients. However this treatment will not improve perinatal outcome, we may now be diagnosing and treating a group of women without sufficient evidence of clinical benefit.</P>

Journal

American Journal of Obstetrics and GynecologyWolters Kluwer Health

Published: Jan 1, 2013

There are no references for this article.